Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity.
Jaka A, Gutiérrez-Rivera A, López-Pestaña A, del Alcázar E, Zubizarreta J, Vildosola S, Arregui MA, Sarasqueta C, Lobo C, Tuneu A.
Actas Dermosifiliogr. 2015; 106: 483-492. FI: 0.000 (Q0).
Treatment of Sézary Syndrome With Alemtuzumab: A Series of 5 Cases and a Review of the Literature.
del Alcázar-Viladomiu E, Tuneu-Valls A, López-Pestaña A, Vidal-Manceñido MJ.
Actas Dermosifiliogr. 2015; 103: e33-9. FI: 0.000 (Q0).
Dyshidrosiform linear immunoglobulin a dermatosis.
Borja-Consigliere HA, Ormaechea-Pérez N, Lobo-Morán C, Tuneu-Valls A.
Actas Dermosifiliogr. 2014; 105: 429-430. FI: 0.000 (Q0).
Aprepitant in the treatment of refractory pruritus secondary to cutaneous T-cell lymphoma.
Borja-Consigliere HA, López-Pestaña A, Vidal-Manceñido MJ, Tuneu-Valls A.
Actas Dermosifiliogr. 2014; 105: 716-718. FI: 0.000 (Q0).
Violaceous nodules on the leg of a patient with multiple myeloma.
Ormaechea-Perez N, Vildosola-Esturo S, Aseginolatza-Zabaleta B, Lobo-Moran C, Jaka-Moreno A, Del alcazar-Viladomiu E, Tuneu-Valls A.
Int. J. Dermatol. 2014; 53: 296-298. FI: 1.227 (Q3).
Pseudoporphyria induced by imatinib mesylate.
Ormaechea N, Vildosola S, Jaka A, Tuneu A.
Int. J. Dermatol. 2014; 53: 143-144. FI: 1.227 (Q3).
Photodistributed neutrophilic dermatosis in a woman with Legionella pneumonitis.
Jaka A, Tuneu A, Ormaechea N, Zubizarreta J.
Int. J. Dermatol. 2014; 53: 209-210. FI: 1.227 (Q3).
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders’ concerns.
Cuende N, Boniface C, Bravery C, Forte M, Giordano R, Hildebrandt M, Izeta A, Dominici M, Int Soc Cellular Therapy.
Cytotherapy. 2014; 16: 1597-1600. FI: 3.100 (Q2).
Purulent Discharge from the Nipples: A Quiz Zuska’s disease.
Tuneu A, Arregui MA, Jaka A, Ormaechea N.
Acta Derm.-Venereol. 2014; 94: 492-0. FI: 4.244 (Q1).
Efectos adversos cutáneos del imatinib (inhibidor de la tirosín cinasa).
Pretel-Irazabal M, Tuneu-Valls A, Ormaechea-Pérez N.
Actas Dermosifiliogr. 2014; 105: 655-662. FI: 0.000 (Q0).
Strategic Plan for the Spanish Academy of Dermatology and Venerology (AEDV): FuturAEDV 2013-2017.
Ribera M, Moreno JC, Valcuende F, Soto J, Vázquez H, Lázaro P, Giménez A.
Actas Dermosifiliogr. 2014; 105: 639-654. FI: 0.000 (Q0).
Neural-Competent Cells of Adult Human Dermis Belong to the Schwann Lineage.
Etxaniz U, Perez-San Vicente A, Gago-Lopez N, Garcia-Dominguez M, Iribar H, Aduriz A, Perez-Lopez V, Burgoa I, Irizar H, Munoz-Culla M, Vallejo-Illarramendi A, Leis O, Matheu A, Martin AG, Otaegui D, Paz Lopez-Mato M, Gutierrez-Rivera A, MacLellan R, Izeta A.
Stem Cell Rep. 2014; 3: 774-788. FI: 0.000 (Q0).
Natural history of prostate cancer.
Estebanez J, Teyrouz A, Gutierrez MA, Linazasoro I, Belloso J, Cano C, Peralta JM, Sanz JP.
Arch Esp Urol. 2014; 67: 383-387. FI: 0.000 (Q0).
Murine Muscle Engineered from Dermal Precursors: An In Vitro Model for Skeletal Muscle Generation, Degeneration, and Fatty Infiltration.
Garcia-Parra P, Naldaiz-Gastesi N, Maroto M, Padin JF, Goicoechea M, Aiastui A, Fernandez-Morales JC, Garcia-Belda P, Lacalle J, Alava JI, Garcia-Verdugo JM, Garcia AG, Izeta A, Lopez de Munain A.
Tissue Eng. Part C-Methods. 2014; 20: 28-41. FI: 0.000 (Q0).
